Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-01-10 @ 10:02 AM
Study NCT ID:
NCT04675827
Status:
TERMINATED
Last Update Posted:
2024-12-04
First Post:
2020-11-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade
Sponsor:
Jules Bordet Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IJB-EBC-Decrescendo-2020
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None